0.00 - 0.01
0.00 - 0.02
1.30M / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-35.79%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
987.72%
Positive gross profit growth while LBL.AX is negative. John Neff would see a clear operational edge over the competitor.
165.89%
Positive EBIT growth while LBL.AX is negative. John Neff might see a substantial edge in operational management.
165.89%
Positive operating income growth while LBL.AX is negative. John Neff might view this as a competitive edge in operations.
479.74%
Positive net income growth while LBL.AX is negative. John Neff might see a big relative performance advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-2.46%
Share reduction while LBL.AX is at 2.48%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-2.46%
Reduced diluted shares while LBL.AX is at 2.48%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-163.38%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-201.42%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
10.79%
10Y revenue/share CAGR under 50% of LBL.AX's 228.01%. Michael Burry would suspect a lasting competitive disadvantage.
119.97%
5Y revenue/share CAGR above 1.5x LBL.AX's 46.12%. David Dodd would look for consistent product or market expansions fueling outperformance.
-28.44%
Negative 3Y CAGR while LBL.AX stands at 25.81%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-1016.95%
Negative 10Y OCF/share CAGR while LBL.AX stands at 45.65%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-462.70%
Negative 5Y OCF/share CAGR while LBL.AX is at 30.04%. Joel Greenblatt would question the firm’s operational model or cost structure.
-47.31%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
336.32%
Net income/share CAGR above 1.5x LBL.AX's 196.67% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
1037.50%
Positive 5Y CAGR while LBL.AX is negative. John Neff might view this as a strong mid-term relative advantage.
-62.50%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
99.31%
5Y equity/share CAGR at 50-75% of LBL.AX's 188.95%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
55.73%
3Y equity/share CAGR above 1.5x LBL.AX's 29.77%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
22.72%
AR growth well above LBL.AX's 32.45%. Michael Burry fears inflated revenue or higher default risk in the near future.
30.13%
Inventory growth well above LBL.AX's 6.76%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-0.81%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
8.82%
Positive BV/share change while LBL.AX is negative. John Neff sees a clear edge over a competitor losing equity.
-10.95%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
133.02%
SG&A growth well above LBL.AX's 28.87%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.